We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$35.5B
AUM Growth
+$586M
(+1.7%)
Cap. Flow
-$946M
Cap. Flow
% of AUM
-2.67%
Top 10 Holdings %
Top 10 Hldgs %
25.54%
Holding
2,317
New
189
Increased
687
Reduced
1,108
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
British American Tobacco
BTI
|
+$104M |
| 2 |
Occidental Petroleum
OXY
|
+$86.7M |
| 3 |
Canadian Imperial Bank of Commerce
CM
|
+$82.9M |
| 4 |
Public Storage
PSA
|
+$71.4M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$57.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$418M |
| 2 |
Consolidated Edison
ED
|
+$212M |
| 3 |
Crown Castle
CCI
|
+$103M |
| 4 |
Target
TGT
|
+$93.8M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 14.38% |
| 2 | Healthcare | 14.1% |
| 3 | Communication Services | 10.76% |
| 4 | Technology | 10.06% |
| 5 | Utilities | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Celldex Therapeutics
CLDX
$3.04B
| $258K | ﹤0.01% |
6,055
-564
| -9% | -$24.2K |
|
|
GGP
1477
DELISTED
GGP Inc.
GGP
| $258K | ﹤0.01% |
11,029
-277,873
| -96% | -$6.19M |
|
|
INOV
1478
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $257K | ﹤0.01% |
+17,144
| New | +$273K |
|
1479
ResMed
RMD
$32.9B
| $255K | ﹤0.01% |
3,015
+2,823
| +1,470% | +$233K |
|
1480
International Flavors & Fragrances
IFF
$21.5B
| $253K | ﹤0.01% |
1,658
+1,566
| +1,702% | +$235K |
|
1481
Independence Realty Trust
IRT
$3.52B
| $252K | ﹤0.01% |
25,000
| – | – |
|
1482
Merit Medical Systems
MMSI
$5.14B
| $251K | ﹤0.01% |
5,814
-1,173
| -17% | -$49.2K |
|
1483
Pentair
PNR
$9.01B
| $250K | ﹤0.01% |
5,265
-670
| -11% | -$31.3K |
|
|
UCTT
1484
Ultra Clean Holdings
UCTT
$3.01B
| $248K | ﹤0.01% |
10,727
+8,647
| +416% | +$222K |
|
|
NBL
1485
DELISTED
Noble Energy, Inc.
NBL
| $248K | ﹤0.01% |
8,497
-3,610
| -30% | -$98.8K |
|
1486
T. Rowe Price
TROW
$21.8B
| $245K | ﹤0.01% |
2,337
-5,948
| -72% | -$580K |
|
|
IPXL
1487
DELISTED
Impax Laboratories, Inc.
IPXL
| $244K | ﹤0.01% |
14,700
-221,526
| -94% | -$4.06M |
|
1488
Cincinnati Financial
CINF
$26.2B
| $243K | ﹤0.01% |
3,226
+3,064
| +1,891% | +$228K |
|
1489
Rexford Industrial Realty
REXR
$8.66B
| $242K | ﹤0.01% |
8,317
-9
| -0.1% | -$271 |
|
1490
Henry Schein
HSIC
$9.67B
| $240K | ﹤0.01% |
4,387
-365
| -8% | -$21.2K |
|
1491
Healthpeak Properties
DOC
$14B
| $236K | ﹤0.01% |
9,067
-13,831
| -60% | -$367K |
|
1492
Crawford & Co Class B
CRD.B
$537M
| $233K | ﹤0.01% |
24,220
| – | – |
|
1493
CarMax
KMX
$8.34B
| $233K | ﹤0.01% |
3,636
+3,045
| +515% | +$217K |
|
1494
Fortune Brands Innovations
FBIN
$4.72B
| $230K | ﹤0.01% |
3,927
-482
| -11% | -$27.4K |
|
|
LOMA
1495
Loma Negra
LOMA
$1.12B
| $230K | ﹤0.01% |
+10,000
| New | +$220K |
|
|
QHC
1496
DELISTED
Quorum Health Corporation
QHC
| $229K | ﹤0.01% |
36,624
-249
| -0.7% | -$1.25K |
|
1497
Expeditors International
EXPD
$24.6B
| $228K | ﹤0.01% |
3,520
-872
| -20% | -$53.4K |
|
1498
BWX Technologies
BWXT
$13.3B
| $225K | ﹤0.01% |
3,721
-82
| -2% | -$4.95K |
|
1499
LKQ Corp
LKQ
$5.82B
| $224K | ﹤0.01% |
5,501
-1,923
| -26% | -$73.6K |
|
1500
Alcoa
AA
$12.2B
| $222K | ﹤0.01% |
+4,131
| New | +$189K |
|
Similar funds
Federated Hermes's Q4 2017 Portfolio in Review
As of Q4 2017, Federated Hermes held 2,317 positions worth $35.5B, up 1.7% from $34.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Federated Hermes's Q4 2017 filing shows 189 new, 687 increased, 1,108 reduced and 152 closed positions. Its largest new stake was Azul: 1,190,200 shares worth $28.4M. The largest sale was AbbVie, an estimated $418M.
By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Communication Services.
- Federated Hermes's largest Q4 2017 buy was Azul: 1,190,200 shares worth $28.4M.
- Federated Hermes added most to British American Tobacco in Q4 2017, an estimated $104M increase.
- Federated Hermes's biggest Q4 2017 reduction was AbbVie, cutting an estimated $418M.
- Federated Hermes fully exited iShares Biotechnology ETF in Q4 2017, selling an estimated $36.1M.
- Federated Hermes's ten largest holdings make up 26% of its $35.5B portfolio in Q4 2017.
- Federated Hermes opened 189 new positions and closed 152 in Q4 2017.
- Federated Hermes's portfolio value rose 1.7% quarter-over-quarter to $35.5B.
Based on Federated Hermes's 13F filing for Q4 2017, filed 14 Feb 2018.